Sandy Draper
Stock Analyst at Guggenheim
(3.37)
# 824
Out of 4,667 analysts
125
Total ratings
52.69%
Success rate
14.3%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $326.09 | +32.48% | 12 | Jul 24, 2024 | |
ACCD Accolade | Maintains: Buy | $13 → $6 | $3.56 | +68.54% | 5 | Jun 28, 2024 | |
IQV IQVIA Holdings | Downgrades: Neutral | n/a | $194.38 | - | 8 | Feb 15, 2024 | |
CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $187.90 | - | 15 | Feb 15, 2024 | |
EVH Evolent Health | Maintains: Hold | $36 → $34 | $11.31 | +200.62% | 9 | Nov 14, 2023 | |
GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.31 | +132.02% | 4 | Aug 10, 2023 | |
DOCS Doximity | Downgrades: Neutral | n/a | $49.90 | - | 3 | Aug 9, 2023 | |
TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.13 | +1,412.86% | 3 | Jun 16, 2023 | |
ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $203.67 | +29.13% | 13 | Apr 28, 2023 | |
AGL agilon health | Maintains: Buy | $21 → $30 | $1.67 | +1,696.41% | 3 | Mar 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $102.96 | -8.70% | 11 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.00 | - | 10 | Oct 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $20.79 | +145.31% | 2 | Aug 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $167.88 | -23.16% | 2 | May 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $39.20 | +40.31% | 2 | May 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $52.70 | +218.79% | 2 | May 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $21.79 | -44.93% | 1 | Apr 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.73 | +24,557.53% | 1 | Mar 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $22.23 | +70.94% | 7 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $3.46 | +1,345.09% | 1 | Jan 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $15.36 | +323.18% | 1 | Jan 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $7.36 | +389.13% | 4 | May 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $210.63 | -20.71% | 3 | Mar 26, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.33 | - | 2 | May 31, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $16.92 | +272.34% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $326.09
Upside: +32.48%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $3.56
Upside: +68.54%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $194.38
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $187.90
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $11.31
Upside: +200.62%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.31
Upside: +132.02%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $49.90
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.13
Upside: +1,412.86%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $203.67
Upside: +29.13%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.67
Upside: +1,696.41%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $102.96
Upside: -8.70%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $9.00
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $20.79
Upside: +145.31%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $167.88
Upside: -23.16%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $39.20
Upside: +40.31%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $52.70
Upside: +218.79%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $21.79
Upside: -44.93%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.73
Upside: +24,557.53%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $22.23
Upside: +70.94%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $3.46
Upside: +1,345.09%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $15.36
Upside: +323.18%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $7.36
Upside: +389.13%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $210.63
Upside: -20.71%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.33
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $16.92
Upside: +272.34%